Active Motif inks global distribution agreement with Arima Genomics for advanced 3D genomics solutions: Carlsbad, California Wednesday, July 8, 2026, 17:00 Hrs [IST] Active Motif, ...
Arima Genomics enters distribution partnership with Active Motif for research-specific Hi-C sequencing kits and services: Carlsbad, California Monday, July 6, 2026, 17:00 Hrs [IST ...
SAN DIEGO--(BUSINESS WIRE)--Arima Genomics, Inc., the leader in 3D genomics, today announced the close of its $7 million Series B Preferred Stock financing round. New investors Genetron Health (NASDAQ ...
SAN DIEGO--(BUSINESS WIRE)--Arima Genomics, Inc., a company focused on research tools to accelerate the understanding of genome sequence and structure toward their role in human health and disease, ...
Arima Genomics, Inc., a cancer diagnostics company bringing DNA sequence and structure together to advance cancer therapy selection, today announced new data to be presented at the Association for ...
CARLSBAD, Calif., May 27, 2026--(BUSINESS WIRE)--Arima Genomics, Inc., a cancer diagnostics company bringing DNA sequence and structure together to advance cancer therapy selection, today announced ...
Arima Genomics, Inc., a company leveraging 3D genomics to reveal actionable insights to improve human health and drive discovery in the life sciences, today announced the formation of a clinical ...
CARLSBAD, Calif., November 06, 2025--(BUSINESS WIRE)--Arima Genomics, Inc., a company leveraging whole-genome sequence and structure information to provide comprehensive cancer therapy selection ...
Arima Genomics, Inc., a cancer diagnostics company bringing DNA sequence and structure together to advance cancer therapy selection, today announced a distribution partnership with Active Motif ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results